Abstracts tagged "seronegative spondyloarthropathy and treatment guidlelines"

Abstract Number: 565 • 2019 ACR/ARP Annual Meeting
Evidence-Based Recommendations for the Management of Enteropathic Arthritis: A Rheumatology – Gastroenterology Collaborative Initiative
Gulen Hatemi ¹, Servet Akar ², Hale Akpinar ³, Pamir Atagunduz ⁴, Goksel Bengi ³, Gercek Can ⁵, Aykut Ferhat Celik ⁶, Sinem Nihal Esatoglu⁷, Onay Gercik ⁸, Hulya Hamzaoglu ⁹, Murat Inanc ¹⁰, Gokhan Kabacam ¹¹, Ismail Hakki Kalkan ¹², Levent Kilic ¹³, Fatos Onen ¹⁴, Ahmet Tezel ¹⁵, Murat Toruner ¹⁶ and Sedat Kiraz ¹³, ¹Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul University-Cerrahpasa, Behcet's Disease Research Center, Istanbul, Turkey, Istanbul, Turkey, ²Izmir Katip Celebi University, Faculty of Medicine, Division of Rheumatology, İzmir, Turkey, ³Dokuz Eylul University, Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology, Izmir, Turkey, ⁴Marmara University Faculty of Medicine,Department of Rheumatology, Istanbul, Turkey, Istanbul, Turkey, ⁵Dokuz Eylul University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Izmir, Izmir, Turkey, ⁶Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Gastroenterology, Istanbul, Turkey, ⁷Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ⁸Izmir Katip Celebi University, Faculty of Medicine, Division of Rheumatology, Izmir, Turkey, ⁹Acibadem University, Acibadem Fulya Hospital, Department of Gastroenterology, Istanbul, Turkey, ¹⁰Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ¹¹Ankara Guven Hospital, Department of Gastroenterology, Ankara, Turkey, ¹²Türkiye Yüksek Ihtisas Training and Research Hospital, Department of Gastroenterology, Ankara, Turkey, ¹³Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, ¹⁴Dokuz Eylul University School of Medicine, Division of Rheumatology, İzmir, Turkey, ¹⁵Trakya University, Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology, Edirne, Turkey, ¹⁶Ankara University School of Medicine, Department of Gastroenterology,, Ankara, Turkey
Background/Purpose: Management of enteropathic arthritis may be challenging due to differences in treatment response of inflammatory bowel diseases and arthritis to different therapeutic modalities, which…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].